Variant report
Variant | nsv1042464 |
---|---|
Chromosome Location | chr11:107337941-107353313 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375138936 | chr11:107344201-107344202 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs568775843 | chr11:107344227-107344228 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs151038844 | chr11:107344242-107344243 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140972020 | chr11:107344247-107344248 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572650588 | chr11:107344354-107344355 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs35220178 | chr11:107344395-107344396 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536184823 | chr11:107344458-107344459 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs733811 | chr11:107344568-107344569 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs185346253 | chr11:107344592-107344593 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573867009 | chr11:107344601-107344602 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544592335 | chr11:107344607-107344608 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563230670 | chr11:107344642-107344643 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs569461362 | chr11:107344667-107344668 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545430363 | chr11:107344715-107344716 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs624584 | chr11:107344724-107344725 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs527797115 | chr11:107344729-107344730 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369684066 | chr11:107344758-107344759 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs373682364 | chr11:107344863-107344864 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189425282 | chr11:107344873-107344874 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568284030 | chr11:107344889-107344890 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373831794 | chr11:107344900-107344901 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550488225 | chr11:107344930-107344931 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs149803854 | chr11:107344973-107344974 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539351527 | chr11:107344979-107344980 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547499092 | chr11:107344998-107344999 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181946369 | chr11:107345027-107345028 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533660941 | chr11:107345049-107345050 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577767616 | chr11:107345089-107345090 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185124826 | chr11:107345214-107345215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533871557 | chr11:107345238-107345239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376722893 | chr11:107345248-107345249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556477775 | chr11:107345249-107345250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs117143906 | chr11:107345355-107345356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181154685 | chr11:107345364-107345365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140990143 | chr11:107345366-107345367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527660050 | chr11:107345373-107345374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543159230 | chr11:107345400-107345401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs77386164 | chr11:107345456-107345457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs144818556 | chr11:107345486-107345487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs550802547 | chr11:107345534-107345535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568950460 | chr11:107345547-107345548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533269240 | chr11:107345602-107345603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551355896 | chr11:107345622-107345623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566145101 | chr11:107345643-107345644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs138756060 | chr11:107345656-107345657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548548049 | chr11:107345683-107345684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567069749 | chr11:107345795-107345796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs78451503 | chr11:107349011-107349012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549061319 | chr11:107349074-107349075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs118141776 | chr11:107349147-107349148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Obesity | 19966786 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:107344200-107345000 | Enhancers | Fetal Kidney | kidney |
2 | chr11:107344200-107345200 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr11:107344600-107345800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr11:107349000-107349600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |